Literature DB >> 10878341

Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells.

A Kitani1, K Chua, K Nakamura, W Strober.   

Abstract

In the present study, we show that human self-MHC-reactive (autoreactive) T cell clones are functionally distinct from Ag-specific T cell clones. Self-MHC-reactive T cells exhibited helper function for B cell Ig production when cultured with non-T cells alone, and they exhibit suppressor function when cultured with PWM- or rCD40 ligand (rCD40L)-activated non-T cells, whereas tetanus toxoid (TT)-specific clones exhibited only helper function in the presence of TT with or without PWM or rCD40L. Addition of neutralizing Abs to the cultures showed that the suppression was mediated by TGF-beta but not by IL-10 or IFN-gamma. The self-MHC-reactive clones also inhibited proliferation of primary CD4+ T cells and TT-specific T cell clones, but in this case the inhibition was mediated by both IL-10 and TGF-beta. In further studies, the interactions between self-MHC-reactive T cell clones and non-T cells that led to suppressor cytokine production have been explored. We found that prestimulation of non-T cells for 8 h with PWM or for 48 h for rCD40L results in non-T cells capable of inducing self-MHC-reactive T cell to produce high levels of TGF-beta and IL-10. In addition, these prestimulation times coincided with peak induction of HLA-DR and costimulatory B7 molecule (especially CD86) expression on B cells. Finally, addition of CTLA-4/Fc or blocking F(ab')2 anti-CTLA-4 mAb, plus optimally stimulated non-T cells, to cultures of self-MHC-reactive clones inhibited the induction of TGF-beta but not IL-10 or IFN-gamma production. In summary, these studies show that activated self-MHC-reactive T cells have the cytokine phenotype of Th3 or T regulatory cell 1 and thus may be important regulatory cells that mediate oral and peripheral tolerance and prevent the development of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878341     DOI: 10.4049/jimmunol.165.2.691

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses.

Authors:  A V Gorbachev; R L Fairchild
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

3.  Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation.

Authors:  T J Sullivan; J J Letterio; A van Elsas; M Mamura; J van Amelsfort; S Sharpe; B Metzler; C A Chambers; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 4.  The role of the thymus in tolerance.

Authors:  Adam D Griesemer; Eric C Sorenson; Mark A Hardy
Journal:  Transplantation       Date:  2010-09-15       Impact factor: 4.939

Review 5.  Making sense of regulatory T cell suppressive function.

Authors:  Itay Shalev; Moritz Schmelzle; Simon C Robson; Gary Levy
Journal:  Semin Immunol       Date:  2011-05-17       Impact factor: 11.130

6.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function.

Authors:  Laura Rivino; Paola Gruarin; Barbara Häringer; Svenja Steinfelder; Laura Lozza; Bodo Steckel; Anja Weick; Elisa Sugliano; David Jarrossay; Anja A Kühl; Christoph Loddenkemper; Sergio Abrignani; Federica Sallusto; Antonio Lanzavecchia; Jens Geginat
Journal:  J Exp Med       Date:  2010-03-01       Impact factor: 14.307

8.  Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.

Authors:  Alon Monsonego; Victor Zota; Arnon Karni; Jeffery I Krieger; Amit Bar-Or; Gal Bitan; Andrew E Budson; Reisa Sperling; Dennis J Selkoe; Howard L Weiner
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 9.  TGF-beta: how tolerant can it be?

Authors:  Sharon M Wahl; Wanjun Chen
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 10.  Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?

Authors:  Kevan C Herold; Lesley Taylor
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.